Johnson & Johnson Vaccine Use Paused
Updated: Sep 15, 2022
Wednesday April 14, 2021
Johnson & Johnson COVID-19 Vaccine has been temporarily paused after cases of a rare side effect emerged.
According to the Federal Drug Administration (FDA), six women have developed blood clots after receiving the Johnson & Johnson vaccine. The decision to temporarily pause the distribution and administration of the vaccine comes from the FDA and the Center for Disease Control (CDC). The pause in the use of the vaccine comes “out of an abundance of caution”.
The rare and severe blood clot occurred in women 18 to 48 and six to 13 days after the shot was administered.
There have been 6.8 million doses of the Johnson & Johnson vaccine administered since the original release. The pause in use of the vaccine has also halted Middle Tennessee State University’s administration of the vaccine.
Wednesday April 14th, 2021 the CDC will convene a meeting of the Advisory Committee on Immunization Practices to further review the cases.
The CDC is asking if anyone who received the Johnson & Johnson vaccine develop any of the following symptoms within three weeks of vaccination to contact their health care provider:
-Shortness of breath
For an additional information on COVID-19 and vaccines visit the CDC’s website https://www.cdc.gov/
This is an ongoing story and will have updates for you as soon as they become available.